Quadrant Capital Group’s Definitive Healthcare DH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-105
Closed -$130 1594
2026
Q1
$130 Sell
105
-34
-24% -$59 ﹤0.01% 2685
2025
Q4
$399 Sell
139
-2,516
-95% -$6.98K ﹤0.01% 2663
2025
Q3
$10.8K Buy
+2,655
New +$10.6K ﹤0.01% 2142
2025
Q2
Sell
-2,790
Closed -$8.06K 1679
2025
Q1
$8.06K Buy
+2,790
New +$11.3K ﹤0.01% 2264
2024
Q3
Sell
-30
Closed -$164 2753
2024
Q2
$164 Buy
+30
New +$189 ﹤0.01% 2677
2023
Q3
Sell
-611
Closed -$6.71K 2703
2023
Q2
$6.71K Buy
611
+488
+397% +$5.02K ﹤0.01% 2137
2023
Q1
$1.27K Hold
123
﹤0.01% 2510
2022
Q4
$1.35K Buy
+123
New +$1.58K ﹤0.01% 2490

Other funds holding DH

Quadrant Capital Group's DH Position: Q2 2026 in Review

Quadrant Capital Group sold out of Definitive Healthcare (DH) in Q2 2026, closing a stake of 105 shares — an estimated $130 sold.

Quadrant Capital Group first reported a position in DH in Q4 2022 and held it in 8 quarters. The position peaked at $10.8K in Q3 2025. 100 funds tracked by Wall St. Rank hold DH as of Q2 2026.

  • Quadrant Capital Group reported no remaining Definitive Healthcare position as of Q2 2026 after selling out during the quarter.
  • Quadrant Capital Group sold 105 Definitive Healthcare shares in Q2 2026, an estimated $130.
  • Quadrant Capital Group first reported a position in Definitive Healthcare in Q4 2022 and held it in 8 quarters.
  • Quadrant Capital Group's Definitive Healthcare position peaked at $10.8K in Q3 2025.
  • 100 funds tracked by Wall St. Rank held Definitive Healthcare as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.